• Users Online: 86
  • Print this page
  • Email this page
Year : 2020  |  Volume : 9  |  Issue : 2  |  Page : 134-140

High-flow nasal cannula: COVID 19 and beyond

1 Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA
2 Department of Nursing, University of Kansas Health System, Kansas City, KS, USA

Correspondence Address:
Dr. Kalpalatha Guntupalli
7200 Cambridge Street, A 10.189, BCM 903, Houston, TX 77030
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijrc.ijrc_47_20

Rights and Permissions

Early case series have suggested that 20%–31% of COVID-19 patients will develop acute respiratory distress syndrome and require intensive care, potentially causing a nationwide shortage of mechanical ventilators. We present a review of the high-flow nasal cannula which presents several physiological benefits in acute respiratory failure. It is a safe treatment modality with low risk of exposure to aerosolized viral particles for health-care workers in the setting of negative-pressure or high-efficiency particulate air-filtered rooms and proper personal protective equipment.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded996    
    Comments [Add]    

Recommend this journal